Overview


According to FutureWise analysis the market for healthcare distribution services is expected to register a CAGR of 6.72% from 2023-2031.

Healthcare distribution is described as the notion of providing patients with various care services such as medications, diagnostic tests, and other facilities. The healthcare system is quite beneficial since it assists individuals in staying healthy. Some of the most frequent forms of healthcare distribution include pharmaceutical product distribution, medical device distribution service, and biopharmaceutical distribution service. Many various technologies and advances are being used by the healthcare business to expand the industry and give better amenities to patients.

The distribution network is critical in the supply chain because it ensures that pharmaceuticals reach customers. A drug's distribution is a vital component of its economic success. To distribute medications, a sophisticated process including several restrictions must be followed. In established economies like as the United States, a few major wholesalers dominate the wholesale industry, selling to regional wholesalers and/or drugstore chains. In most underdeveloped nations, however, drug distribution is a difficult and fragmented industry. Small wholesalers and the lack of established retail chains complicate the procedure in these nations. Healthcare distribution refers to the provision of various care services to patients, such as medications, diagnostic tests, and other facilities.

The healthcare system is extremely beneficial since it keeps people healthy. Some of the most frequent kinds of healthcare distribution are pharmaceutical distribution, medical device distribution, and biopharmaceutical distribution. Many various technologies and advances are being used to enhance the healthcare business and provide better patient care. Today, pharmaceutical merchants are stepping up their efforts to ensure the correct distribution of pharmaceutical items. By supplying healthcare supplies and services in a secure and efficient manner, they are also contributing to patient security. Pharmaceutical commodities are kept and delivered from manufacturing plants to wholesalers, patients, or hospitals in the healthcare distribution sector.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Healthcare Distribution Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Healthcare Distribution Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • FFF Enterprises
  • Owens Minor, Inc.
  • McKesson Corporation
  • Mutual Drug
  • CuraScript SD
  • Rochester Drug Cooperative, Inc.
  • Medline Industries
  • Patterson Companies Inc.
  • AmerisourceBergen Corporation
  •  Morris and Dickson Co. 
  • Henry Schein Inc.
  • Smith Drug Company

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Pharmaceutical Product Distribution Services
    • OTC Drugs/Vitamins
    • Generic Drugs
    • Brand-Name/Innovator Drugs
    • Technology Collaborations
    • Strategic Divestments
  • Medical Device Distribution Services
  • Biopharmaceutical Product Distribution Services
    • Joint Ventures
    • Mergers and Acquisitions
    • Licensing and Partnership
    • Technology Collaborations
    • Strategic Divestments

By End User

  • Retail Pharmacies
  • Hospital Pharmacies
  • Other End Users

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Healthcare Distribution Services Market By Type, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
  • To forecast and evaluate micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record , evaluate and analyze competitive landscape mapping- technological advancements, product launches, expansions and mergers

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Healthcare Distribution Services Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Healthcare Distribution Services Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Healthcare Distribution Services Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Healthcare Distribution Services Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Healthcare Distribution Services Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical Product Distribution Services
         1.1. OTC Drugs/Vitamins
         1.2. Generic Drugs
         1.3. Brand-name/Innovator Drugs
         1.4. Technology Collaborations
         1.5. Strategic Divestments
        2. Medical Device Distribution Services
        3. Biopharmaceutical Product Distribution Services
         3.1. Joint Ventures
         3.2. Mergers and Acquisition
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments

  • 8.   Healthcare Distribution Services Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Retail Pharmacies
        2. Hospital Pharmacies
        3. Other

  • 9.   North America Healthcare Distribution Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Healthcare Distribution Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Healthcare Distribution Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Healthcare Distribution Services Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
    •   1. FFF Enterprises
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Owens Minor, Inc.
                 2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. McKesson Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Mutual Drug
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. CuraScript SD
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Rochester Drug Cooperative, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7 . Medline Industries
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Patterson Companies Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. AmerisourceBergen Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Morris and Dickson Co.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Henry Schein Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Smith Drug Company
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients